China Universal Asset Management Company’s Faeth Therapeutics FTH Stock Holding History

China Universal Asset Management Company’s Portfolio FTH Stock Details FTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90K	Buy	+3,600	New	+$83.3K	0.01%	424
2022 Q4	–	Sell	-14	Closed	–	–	458
2022 Q3	$0	Buy	+14	New	+$550	﹤0.01%	460

Other funds holding FTH

RIS

Richmond Investment Services Mequon, Wisconsin $316M AUM 30.61% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

China Universal Asset Management Company's FTH Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Faeth Therapeutics (FTH) in Q2 2026: 3,600 shares worth $90K. The stake represents 0.01% of the portfolio and ranks #424 among its holdings. This is a return to the name: China Universal Asset Management Company previously reported a position in FTH as recently as Q3 2022.

China Universal Asset Management Company first reported a position in FTH in Q3 2022 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

China Universal Asset Management Company held 3,600 shares of Faeth Therapeutics worth $90K as of Q2 2026.
Faeth Therapeutics was a new China Universal Asset Management Company position in Q2 2026.
Faeth Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #424 holding.
China Universal Asset Management Company first reported a position in Faeth Therapeutics in Q3 2022 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.